XLXiaoqi Li

Xiaoqi Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaoqi Li has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Chuyue Zhang

    State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing, China

    1 shared publication
  • Deyi Zhuo

    Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China

    1 shared publication
  • Hao Wen

    State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asia, Xinjiang Medical University, China

    1 shared publication
  • Huiyi Wang

    Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China

    1 shared publication
  • Junyi Wang

    Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China

    1 shared publication
  • Limin Qin

    Department of Ophthalmology, The Third Medical Center, Chinese PLA General Hospital, Beijing, China

    1 shared publication

Latest Publications

  • Cellular Localization of FOXO3 Determines Its Role in Cataractogenesis

    by Xiaoqi Li, Yingxin Qu, Qinghua Yang, Runpu Li, Yumei Diao, Junyi Wang, Lingling Wu, Chuyue Zhang, Shaoyuan Cui, Limin Qin, et al.


  • Open Access

    Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma via IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia

    by Xiaotian Han, Yechen Lu, Xiaoqi Li, Lingfang Xia, Hao Wen, Zheng Feng, Xingzhu Ju, Xiaojun Chen, Xiaohua Wu

    Background: Epithelial ovarian cancer (EOC) is the main subtype of ovarian cancer and shows an aggressive phenotype and poor prognosis. Neuronal pentraxin II (NPTX2) is a member of the neuronal pentraxin family and plays a contradictory role in different tumors. However, there has been no report about the possible role and effect of NPTX2 in EOC.Methods: Bioinformatics analysis, qPCR, western blotting and immunohistochemistry were used to detect the expression of NPTX2 in EOC. Lentivirus-based transfection for NPTX2 overexpression or knockdown was performed on the EOC cell lines A2780, HEY, SKOV3 and OVCAR-3. The effect of NPTX2 on the malignant phenotype of EOC was examined through methods of MTS assay, Edu assay, transwell assay, western blotting analysis, qPCR analysis, luciferase reporter assay and xenograft experiment.Results: EOC tissues showed higher NPTX2 expression than the normal tissues with poor prognosis. NPTX2 overexpression can promote the proliferation, invasion, migration and tumorigenesis of EOC via IL6-JAK2/STAT3 signaling pathway. Moreover, hypoxia-inducible factor-1(HIF-1) can promote the transcription and expression of NPTX2 under the hypoxic environment. NPTX2 knockdown abolished the hypoxia-induced malignant phenotypes in ECO.Conclusions: The above results suggest that NPTX2 may play a novel role in ovarian cancer’s malignant phenotype and act as a promising treatment target for EOC molecular therapy.